Phadia 1000 Instrument, Article Number 12-3800-01.
Published January 24, 2018 · Recall initiated: July 5, 2017
Summary
FDA records medical device Class II recall Z-0387-2018, published January 24, 2018 and initiated July 5, 2017. Recalling firm: Phadia US Inc; Status: Terminated; Reported quantity: 70 units; Lot: All versions of the instrument. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The "Retry" command does not function properly which could cause a shortage of Wash and Rinse solution and affect assay performance and test results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Phadia US Inc
- Distributor
- Nationwide
- Lot
- All versions of the instrument
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAIbuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipperJanuary 31, 2018
- FDAUnifine Pentips 5mm x 31G pen needles, packaged in 30 ct pen needles. Product Usage: Sterile, non-toxic,January 24, 2018
- FDAIngenuity Core 128, (Code 728323) Intended to produce images of the head and body by computer reconstructionJanuary 24, 2018
- FDAPROPONENT SR PacemakerJanuary 24, 2018
- FDAVISIONIST CRT-P PacemakerJanuary 24, 2018
- FDAPHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)September 5, 2012
Questions about this recall
Was Phadia 1000 Instrument, Article Number 12-3800-01. recalled?
Yes. FDA published recall Z-0387-2018 on January 24, 2018. Reported hazard: The "Retry" command does not function properly which could cause a shortage of Wash and Rinse solution and affect assay performance and test results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter